Ryman Healthcare Limited (RYHTY)
 OTCMKTS  · Delayed Price · Currency is USD  
8.00
 0.00 (0.00%)
  Oct 29, 2025, 4:00 PM EDT
Ryman Healthcare Market Cap
Ryman Healthcare has a market cap or net worth of $1.67 billion as of October 30, 2025. Its market cap has decreased by -19.74% in one year.
Market Cap 
 1.67B
Enterprise Value 
 2.64B
Revenue 
 430.24M
Ranking 
 n/a
PE Ratio 
 n/a
Stock Price 
$8.00
Market Cap Chart
Since June 6, 2000, Ryman Healthcare's market cap has increased from 81.02M to 1.67B, an increase of 1,964.40%. That is a compound annual growth rate of 12.65%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 1.67B | -7.57% | 
| Dec 31, 2024 | 1.81B | -29.31% | 
| Dec 29, 2023 | 2.56B | 49.85% | 
| Dec 30, 2022 | 1.71B | -59.03% | 
| Dec 31, 2021 | 4.17B | -23.30% | 
| Dec 31, 2020 | 5.44B | -0.79% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro | 
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Veradigm | 815.18M | 
| Elite Pharmaceuticals | 648.67M | 
| Glass House Brands | 563.30M | 
| Northwest Biotherapeutics | 366.55M | 
| Silence Therapeutics | 341.50M | 
| Nika Pharmaceuticals | 312.10M | 
| CytoDyn | 303.60M | 
| American Oncology Network | 297.14M |